Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4576

TDMS Study 05187-06 Pathology Tables

NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98
Route: GAVAGE                                                                                                     Time: 10:15:51

                                                           CORE STUDY




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  93-15-2

       Lock Date:  06/12/96

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 


  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 5            7            8           13                                     
    Natural Death                                     14           24           23           35                                     
    Dosing Accident                                                 1            1                                                  
  Survivors                                                                                                                         
    Natural Death                                                                2                                                  
    Terminal Sacrifice                                31           18           16            2                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (38)         (28)         (30)         (24)                                   
      Infiltration Cellular, Lymphocyte                             1 (4%)                                                          
   Intestine Small, Duodenum                          (46)         (49)         (46)         (43)                                   
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Parasite Metazoan                                             1 (2%)                                                          
      Ulcer                                                                      1 (2%)                                             
      Epithelium, Necrosis                                          1 (2%)                                                          
   Intestine Small, Jejunum                           (46)         (46)         (40)         (40)                                   
      Inflammation, Suppurative                                     1 (2%)                                                          
      Ulcer                                                         1 (2%)                                                          
   Liver                                              (50)         (50)         (49)         (50)                                   
      Atrophy                                                                    1 (2%)                                             
      Basophilic Focus                                 5 (10%)      2 (4%)                    3 (6%)                                
      Clear Cell Focus                                 1 (2%)       2 (4%)                    1 (2%)                                
      Cyst                                             1 (2%)                                                                       
      Eosinophilic Focus                               5 (10%)      9 (18%)      4 (8%)       9 (18%)                               
      Fibrosis                                         1 (2%)       2 (4%)       3 (6%)                                             
      Hematopoietic Cell Proliferation                 4 (8%)      14 (28%)     23 (47%)     24 (48%)                               
      Infiltration Cellular, Lymphocyte               23 (46%)     18 (36%)     21 (43%)     19 (38%)                               
      Inflammation, Chronic Active                    24 (48%)     25 (50%)     16 (33%)     10 (20%)                               
      Inflammation, Suppurative                                                               1 (2%)                                
      Mineralization                                   1 (2%)       2 (4%)                                                          
      Mixed Cell Focus                                 7 (14%)      3 (6%)                                                          
      Pigmentation, Hemosiderin                                    11 (22%)     24 (49%)     19 (38%)                               
      Tension Lipidosis                                2 (4%)                                                                       
      Bile Duct, Cyst                                               1 (2%)       6 (12%)      3 (6%)                                
      Bile Duct, Cyst, Multiple                        1 (2%)                                                                       
      Bile Duct, Hyperplasia                           1 (2%)       1 (2%)      11 (22%)      9 (18%)                               
      Hepatocyte, Atypia Cellular                                   1 (2%)                                                          
      Hepatocyte, Hyperplasia, Adenomatous                                                    1 (2%)                                
      Hepatocyte, Necrosis                             5 (10%)      9 (18%)     16 (33%)     17 (34%)                               
      Hepatocyte, Vacuolization Cytoplasmic           20 (40%)     14 (28%)     11 (22%)     12 (24%)                               

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Centrilobular, Atrophy                                                      1 (2%)                                
      Oval Cell, Hyperplasia                                       46 (92%)     36 (73%)     38 (76%)                               
      Portal, Hypertrophy                                          10 (20%)      7 (14%)     23 (46%)                               
   Mesentery                                          (13)         (7)          (3)          (3)                                    
      Inflammation, Chronic Active                     1 (8%)                                                                       
      Inflammation, Suppurative                                                               1 (33%)                               
      Artery, Inflammation, Chronic Active                          1 (14%)                                                         
      Artery, Necrosis, Fibrinoid                                   1 (14%)                                                         
      Fat, Necrosis                                    6 (46%)      3 (43%)      1 (33%)      1 (33%)                               
   Pancreas                                           (49)         (50)         (46)         (46)                                   
      Infiltration Cellular, Lymphocyte               10 (20%)     15 (30%)     13 (28%)      2 (4%)                                
      Acinus, Atrophy                                               1 (2%)                                                          
      Artery, Inflammation, Chronic Active                          1 (2%)                                                          
      Artery, Necrosis, Fibrinoid                                   1 (2%)                                                          
   Salivary Glands                                    (50)         (45)         (44)         (42)                                   
      Infiltration Cellular, Lymphocyte               33 (66%)     29 (64%)     27 (61%)     18 (43%)                               
   Stomach, Forestomach                               (50)         (50)         (48)         (46)                                   
      Diverticulum                                                               1 (2%)                                             
      Hyperkeratosis                                   1 (2%)       3 (6%)                    3 (7%)                                
      Inflammation, Chronic Active                                  2 (4%)       1 (2%)                                             
      Epithelium, Hyperplasia, Squamous                1 (2%)       3 (6%)       2 (4%)       1 (2%)                                
      Epithelium, Ulcer                                             2 (4%)                                                          
   Stomach, Glandular                                 (45)         (49)         (46)         (45)                                   
      Atrophy                                                                   10 (22%)     10 (22%)                               
      Ectasia                                         14 (31%)     33 (67%)     31 (67%)     38 (84%)                               
      Hyperplasia                                                   1 (2%)       5 (11%)      2 (4%)                                
      Hyperplasia, Atypical                                                                   1 (2%)                                
      Inflammation, Chronic Active                    17 (38%)     21 (43%)     12 (26%)     14 (31%)                               
      Mineralization                                   2 (4%)       1 (2%)       2 (4%)       3 (7%)                                
      Necrosis                                                      1 (2%)       3 (7%)       2 (4%)                                
      Neuroendocrine Cell, Hyperplasia                              1 (2%)                                                          
   Tooth                                              (2)          (1)                                                              
      Inflammation, Chronic Active                     1 (50%)      1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (49)         (47)                                   
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
   Heart                                              (50)         (50)         (48)         (44)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   2 (4%)       1 (2%)       1 (2%)                                             
      Artery, Inflammation, Chronic Active                          1 (2%)                                                          
      Atrium, Thrombosis                               1 (2%)       3 (6%)       6 (13%)      9 (20%)                               
      Valve, Inflammation, Suppurative                                                        1 (2%)                                
      Valve, Thrombosis                                                                       1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Degeneration, Fatty                              1 (2%)                                 1 (2%)                                
      Hematopoietic Cell Proliferation                 2 (4%)       8 (16%)     17 (34%)     14 (29%)                               
      Pigmentation, Hemosiderin                                                               1 (2%)                                
      Subcapsular, Hyperplasia                        47 (94%)     48 (96%)     49 (98%)     48 (98%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   1 (2%)       7 (14%)      5 (10%)                               
   Islets, Pancreatic                                 (49)         (50)         (46)         (47)                                   
      Hyperplasia                                      8 (16%)      3 (6%)       1 (2%)       2 (4%)                                
   Parathyroid Gland                                  (36)         (40)         (38)         (36)                                   
      Cyst                                             1 (3%)       1 (3%)                                                          
   Pituitary Gland                                    (48)         (44)         (44)         (40)                                   
      Pars Distalis, Angiectasis                       7 (15%)                                                                      
      Pars Distalis, Cyst                              1 (2%)                    1 (2%)       1 (3%)                                
      Pars Distalis, Hyperplasia                       6 (13%)      8 (18%)      3 (7%)       3 (8%)                                
   Thyroid Gland                                      (50)         (46)         (46)         (42)                                   
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Follicle, Cyst                                                1 (2%)       1 (2%)                                             
      Follicular Cell, Hyperplasia                     8 (16%)     10 (22%)      7 (15%)      5 (12%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (47)         (47)         (46)         (44)                                   
      Cyst                                                          2 (4%)                                                          
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
   Ovary                                              (50)         (49)         (48)         (41)                                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Cyst                                            12 (24%)      7 (14%)      7 (15%)      4 (10%)                               
      Infiltration Cellular, Lymphocyte                             1 (2%)       1 (2%)                                             
      Mineralization                                   1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Thrombosis                                                                              2 (5%)                                
   Uterus                                             (50)         (50)         (49)         (47)                                   
      Hemorrhage                                                                              1 (2%)                                
      Hydrometra                                      25 (50%)     24 (48%)     15 (31%)      5 (11%)                               
      Hyperplasia, Cystic                             19 (38%)     10 (20%)                   2 (4%)                                
      Infiltration Cellular, Lymphocyte                1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                                  1 (2%)                                                          

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (48)         (50)                                   
      Hyperplasia                                     18 (36%)     47 (94%)     46 (96%)     50 (100%)                              
      Myelofibrosis                                   10 (20%)      7 (14%)      3 (6%)       3 (6%)                                
   Lymph Node                                         (13)         (7)          (8)          (4)                                    
      Inguinal, Infiltration Cellular, Mast Cell                                              1 (25%)                               
      Lumbar, Ectasia                                               1 (14%)                                                         
      Mediastinal, Hyperplasia, Lymphoid               2 (15%)                                                                      
      Mediastinal, Necrosis                                         1 (14%)                                                         
      Pancreatic, Hyperplasia                                       1 (14%)                                                         
      Renal, Ectasia                                   1 (8%)                                                                       
   Lymph Node, Mandibular                             (49)         (43)         (41)         (32)                                   
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Hyperplasia, Plasma Cell                         1 (2%)                                                                       
   Lymph Node, Mesenteric                             (47)         (48)         (43)         (36)                                   
      Angiectasis                                                   1 (2%)       1 (2%)                                             
      Ectasia                                          1 (2%)       2 (4%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                              1 (2%)       1 (2%)                                             
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Necrosis                                         1 (2%)       1 (2%)                                                          
   Spleen                                             (50)         (50)         (46)         (46)                                   
      Atrophy                                                                                 1 (2%)                                
      Fibrosis                                                                   1 (2%)                                             
      Necrosis                                         1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Lymphoid Follicle, Depletion Cellular                         1 (2%)                    2 (4%)                                
      Lymphoid Follicle, Hyperplasia, Lymphoid         8 (16%)      3 (6%)       2 (4%)                                             
      Lymphoid Follicle, Necrosis                                   2 (4%)       4 (9%)       1 (2%)                                
      Red Pulp, Hematopoietic Cell Proliferation      29 (58%)     40 (80%)     45 (98%)     44 (96%)                               
   Thymus                                             (45)         (43)         (40)         (33)                                   
      Cyst                                            14 (31%)      9 (21%)      5 (13%)      7 (21%)                               
      Ectopic Parathyroid Gland                                                               1 (3%)                                
      Thymocyte, Necrosis                                           2 (5%)       3 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (48)         (50)         (37)                                   
      Hyperplasia, Cystic                              1 (2%)       1 (2%)                                                          
   Skin                                               (50)         (50)         (50)         (49)                                   
      Subcutaneous Tissue, Infiltration Cellular,                                                                                   
           Lymphocyte                                  1 (2%)                    2 (4%)       2 (4%)                                
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (2)          (8)          (3)          (3)                                    
      Infiltration Cellular, Lymphocyte                             5 (63%)      1 (33%)      2 (67%)                               
      Artery, Inflammation, Chronic Active                          1 (13%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Peripheral Nerve                                                (1)                                                              
      Demyelination                                                 1 (100%)                                                        
   Spinal Cord                                                     (1)                                                              
      Demyelination                                                 1 (100%)                                                        
      Artery, Inflammation, Chronic Active                          1 (100%)                                                        
      Artery, Necrosis, Fibrinoid                                   1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (48)         (45)                                   
      Infiltration Cellular, Lymphocyte                1 (2%)       1 (2%)                    1 (2%)                                
      Inflammation, Chronic Active                                  1 (2%)                    2 (4%)                                
      Inflammation, Suppurative                                                               1 (2%)                                
      Metaplasia, Osseous                                                                     1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 2 (4%)       1 (2%)                                                          
      Alveolus, Infiltration Cellular, Histiocyte      1 (2%)       1 (2%)       2 (4%)       4 (9%)                                
      Bronchiole, Exudate, Organized                                             1 (2%)                                             
      Mediastinum, Inflammation, Chronic Active                                  1 (2%)                                             
      Mediastinum, Necrosis                                                      1 (2%)                                             
   Nose                                               (50)         (50)         (49)         (47)                                   
      Inflammation, Suppurative                        8 (16%)     11 (22%)     13 (27%)     11 (23%)                               
      Nasolacrimal Duct, Inflammation, Suppurative     4 (8%)      15 (30%)     11 (22%)     12 (26%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)                       (1)                                                 
      Atrophy                                                                    1 (100%)                                           
      Hemorrhage                                       1 (50%)                                                                      
      Inflammation, Suppurative                        1 (50%)                                                                      
      Cornea, Inflammation, Chronic Active             1 (50%)                                                                      
   Harderian Gland                                    (5)          (2)          (2)                                                 
      Inflammation, Suppurative                                                  1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (49)                                   
      Accumulation, Hyaline Droplet                    1 (2%)       3 (6%)                                                          
      Hydronephrosis                                                                          2 (4%)                                
      Infiltration Cellular, Lymphocyte               28 (56%)     29 (58%)     29 (58%)     23 (47%)                               
      Metaplasia, Osseous                              2 (4%)       1 (2%)                    1 (2%)                                
      Mineralization                                   1 (2%)       3 (6%)       2 (4%)       2 (4%)                                
      Necrosis                                                                   1 (2%)                                             
      Nephropathy                                     10 (20%)     13 (26%)      9 (18%)     10 (20%)                               
      Artery, Inflammation, Chronic Active                          2 (4%)                                                          
      Cortex, Cyst                                                  1 (2%)                    2 (4%)                                
      Glomerulus, Amyloid Deposition                                                          1 (2%)                                
      Renal Tubule, Hyperplasia                                                  1 (2%)                                             
      Renal Tubule, Pigmentation, Hemosiderin                                    2 (4%)       2 (4%)                                
   Urinary Bladder                                    (50)         (49)         (47)         (46)                                   
      Infiltration Cellular, Lymphocyte               20 (40%)     29 (59%)     27 (57%)     25 (54%)                               
      Inflammation, Chronic Active                     2 (4%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 


  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 5            6            5            9                                     
    Natural Death                                      6            8            7            4                                     
    Accidently Killed                                                            1            1                                     
    Dosing Accident                                                                           1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                38           36           37           35                                     
  Missing                                              1                                                                            

  Animals Examined Microscopically                    49           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Duodenum                          (47)         (47)         (48)         (50)                                   
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Ulcer                                                         1 (2%)                                                          
   Intestine Small, Jejunum                           (49)         (49)         (48)         (48)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Peyer's Patch, Hyperplasia, Lymphoid             1 (2%)       1 (2%)                                                          
      Peyer's Patch, Inflammation, Suppurative                                                1 (2%)                                
   Liver                                              (49)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Atrophy                                                                                 1 (2%)                                
      Basophilic Focus                                 5 (10%)      3 (6%)       1 (2%)       3 (6%)                                
      Clear Cell Focus                                16 (33%)      8 (16%)      2 (4%)       6 (12%)                               
      Eosinophilic Focus                              10 (20%)     20 (40%)     25 (50%)     19 (38%)                               
      Fibrosis                                         1 (2%)       4 (8%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                 3 (6%)       9 (18%)      7 (14%)      9 (18%)                               
      Infiltration Cellular, Lymphocyte                6 (12%)      5 (10%)     12 (24%)     10 (20%)                               
      Inflammation, Chronic Active                    19 (39%)     21 (42%)     28 (56%)     28 (56%)                               
      Mineralization                                                3 (6%)       1 (2%)                                             
      Mixed Cell Focus                                 9 (18%)     13 (26%)      9 (18%)      7 (14%)                               
      Pigmentation, Hemosiderin                        3 (6%)       5 (10%)      6 (12%)      5 (10%)                               
      Tension Lipidosis                                             1 (2%)                                                          
      Bile Duct, Cyst                                               1 (2%)       1 (2%)                                             
      Bile Duct, Hyperplasia                                        1 (2%)                    1 (2%)                                
      Hepatocyte, Necrosis                             8 (16%)     14 (28%)      8 (16%)     10 (20%)                               
      Hepatocyte, Vacuolization Cytoplasmic            7 (14%)      7 (14%)      2 (4%)      13 (26%)                               
      Hepatocyte, Centrilobular, Atrophy                                         1 (2%)                                             
      Hepatocyte, Centrilobular, Necrosis                                                     2 (4%)                                
      Oval Cell, Hyperplasia                                        8 (16%)     27 (54%)     46 (92%)                               
      Portal, Hypertrophy                                           1 (2%)       7 (14%)     46 (92%)                               
   Mesentery                                          (1)          (2)          (1)          (1)                                    
      Thrombosis                                       1 (100%)                                                                     

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Necrosis                                                              1 (100%)                                           
   Pancreas                                           (49)         (49)         (50)         (50)                                   
      Cyst                                             1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Lymphocyte                1 (2%)       4 (8%)                    4 (8%)                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Acinus, Atrophy                                  3 (6%)                                                                       
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
   Salivary Glands                                    (49)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte               31 (63%)     29 (58%)     28 (56%)     34 (68%)                               
   Stomach, Forestomach                               (49)         (50)         (50)         (50)                                   
      Hyperkeratosis                                                1 (2%)       4 (8%)                                             
      Hyperplasia, Squamous                            1 (2%)                                                                       
      Inflammation, Chronic Active                     2 (4%)                    3 (6%)                                             
      Epithelium, Hyperplasia, Squamous                5 (10%)      2 (4%)       3 (6%)       2 (4%)                                
      Epithelium, Ulcer                                                          1 (2%)                                             
   Stomach, Glandular                                 (49)         (48)         (49)         (50)                                   
      Atrophy                                                       3 (6%)      35 (71%)     45 (90%)                               
      Ectasia                                         13 (27%)     25 (52%)     40 (82%)     49 (98%)                               
      Hyperplasia                                                   1 (2%)      15 (31%)     20 (40%)                               
      Hyperplasia, Atypical                                                      1 (2%)       2 (4%)                                
      Inflammation, Chronic Active                    10 (20%)     11 (23%)     25 (51%)     33 (66%)                               
      Inflammation, Suppurative                                                               1 (2%)                                
      Mineralization                                                1 (2%)       1 (2%)       4 (8%)                                
      Necrosis                                                                   1 (2%)                                             
      Neuroendocrine Cell, Hyperplasia                                                        4 (8%)                                
   Tooth                                              (23)         (13)         (4)          (5)                                    
      Inflammation, Chronic Active                     1 (4%)       1 (8%)                    1 (20%)                               
      Malformation                                    22 (96%)     12 (92%)      4 (100%)     4 (80%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (50)         (50)         (50)                                   
      Cardiomyopathy                                                1 (2%)                    2 (4%)                                
      Mineralization                                                1 (2%)                    1 (2%)                                
      Artery, Inflammation, Chronic Active                          1 (2%)                    1 (2%)                                
      Atrium, Thrombosis                               1 (2%)       1 (2%)                    2 (4%)                                
      Valve, Inflammation, Suppurative                              1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (49)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                             2 (4%)                                                          
      Angiectasis                                                   1 (2%)       1 (2%)       1 (2%)                                
      Degeneration, Fatty                              1 (2%)       1 (2%)                                                          

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hypertrophy                                                   5 (10%)      3 (6%)       2 (4%)                                
      Pigmentation, Hemosiderin                                                  1 (2%)                                             
      Subcapsular, Hyperplasia                        38 (78%)     42 (84%)     44 (88%)     43 (86%)                               
   Islets, Pancreatic                                 (49)         (49)         (50)         (50)                                   
      Hyperplasia                                     32 (65%)     26 (53%)     18 (36%)     17 (34%)                               
   Pituitary Gland                                    (45)         (48)         (44)         (45)                                   
      Pars Distalis, Cyst                              5 (11%)      7 (15%)      3 (7%)       1 (2%)                                
   Thyroid Gland                                      (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                  1 (2%)                    3 (6%)                                
      Follicle, Cyst                                   2 (4%)       2 (4%)       2 (4%)       2 (4%)                                
      Follicular Cell, Hyperplasia                     2 (4%)       7 (14%)      6 (12%)      5 (10%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      Infiltration Cellular, Lymphocyte                1 (2%)       1 (2%)                    2 (4%)                                
      Mineralization                                                1 (2%)                                                          
   Preputial Gland                                    (49)         (50)         (50)         (50)                                   
      Cyst                                             7 (14%)      6 (12%)     10 (20%)      5 (10%)                               
      Infiltration Cellular, Lymphocyte               17 (35%)     15 (30%)     14 (28%)     18 (36%)                               
      Inflammation, Chronic Active                     3 (6%)       4 (8%)       8 (16%)      2 (4%)                                
   Prostate                                           (49)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Inflammation, Chronic Active                     2 (4%)       2 (4%)                                                          
      Artery, Inflammation, Chronic Active                          1 (2%)                                                          
   Seminal Vesicle                                    (49)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                        1 (2%)                                                                       
   Testes                                             (49)         (50)         (50)         (50)                                   
      Germinal Epithelium, Atrophy                                  1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (49)         (50)         (50)                                   
      Atrophy                                                                    1 (2%)                                             
      Hyperplasia                                     14 (29%)     26 (53%)     33 (66%)     35 (70%)                               
      Infiltration Cellular, Mast Cell                 1 (2%)                                                                       
      Necrosis                                                                   1 (2%)                                             
   Lymph Node                                         (3)          (4)          (5)          (3)                                    
      Lumbar, Hyperplasia, Plasma Cell                 1 (33%)                                                                      

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Mediastinal, Necrosis                            1 (33%)                                                                      
      Renal, Hyperplasia, Plasma Cell                  1 (33%)                                                                      
   Lymph Node, Mandibular                             (48)         (46)         (47)         (45)                                   
      Hyperplasia, Lymphoid                                                      2 (4%)                                             
      Hyperplasia, Plasma Cell                                                   1 (2%)                                             
      Necrosis                                                      1 (2%)                                                          
   Lymph Node, Mesenteric                             (49)         (46)         (49)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Atrophy                                          1 (2%)                                                                       
      Congestion                                                                 1 (2%)                                             
      Ectasia                                                       1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                 2 (4%)                    1 (2%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Hyperplasia, Lymphoid                                                      2 (4%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Necrosis                                         2 (4%)       2 (4%)                    1 (2%)                                
   Spleen                                             (49)         (49)         (50)         (50)                                   
      Atrophy                                                                    2 (4%)                                             
      Fibrosis                                                      1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
      Pigmentation, Hemosiderin                                     1 (2%)                                                          
      Lymphoid Follicle, Hyperplasia, Lymphoid         1 (2%)                    1 (2%)       3 (6%)                                
      Lymphoid Follicle, Necrosis                      3 (6%)       6 (12%)      1 (2%)       2 (4%)                                
      Red Pulp, Erythrophagocytosis                                 1 (2%)                                                          
      Red Pulp, Hematopoietic Cell Proliferation      10 (20%)     20 (41%)     25 (50%)     19 (38%)                               
   Thymus                                             (37)         (40)         (38)         (45)                                   
      Cyst                                            10 (27%)     19 (48%)     16 (42%)     12 (27%)                               
      Ectopic Parathyroid Gland                                     1 (3%)                    1 (2%)                                
      Thymocyte, Necrosis                              1 (3%)       1 (3%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (50)         (50)         (50)                                   
      Subcutaneous Tissue, Inflammation,                                                                                            
          Suppurative                                                                         1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (2)          (1)          (3)          (3)                                    
      Infiltration Cellular, Lymphocyte                1 (50%)                   2 (67%)      1 (33%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (49)         (50)         (50)         (50)                                   
      Necrosis                                         1 (2%)                                                                       
   Spinal Cord                                        (2)                                    (2)                                    
      Hemorrhage                                                                              1 (50%)                               
      Nerve, Demyelination                                                                    1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphocyte                                                       1 (2%)                                
      Inflammation, Chronic Active                     2 (4%)       2 (4%)                                                          
      Inflammation, Suppurative                        1 (2%)                    1 (2%)                                             
      Thrombosis                                                    2 (4%)                    1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 7 (14%)      6 (12%)      5 (10%)      5 (10%)                               
      Alveolus, Infiltration Cellular, Lymphocyte                                1 (2%)                                             
      Alveolus, Infiltration Cellular, Histiocyte      2 (4%)       1 (2%)                    2 (4%)                                
      Bronchiole, Hyperplasia                          1 (2%)                                                                       
      Mediastinum, Inflammation, Chronic Active                                               1 (2%)                                
      Mediastinum, Necrosis                                                                   1 (2%)                                
   Nose                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Inflammation, Suppurative                        9 (18%)     13 (26%)     11 (22%)     10 (20%)                               
      Polyp, Inflammatory                              1 (2%)       1 (2%)                                                          
      Nasolacrimal Duct, Inflammation, Suppurative     4 (8%)       2 (4%)       8 (16%)      2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (1)          (1)                                    
      Cornea, Inflammation, Chronic Active                                       1 (100%)     1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphocyte               29 (59%)     32 (64%)     27 (54%)     40 (80%)                               
      Inflammation, Chronic Active                                                            1 (2%)                                
      Inflammation, Suppurative                        1 (2%)       1 (2%)                    1 (2%)                                
      Metaplasia, Osseous                              1 (2%)       3 (6%)                    1 (2%)                                
      Mineralization                                                1 (2%)       3 (6%)       4 (8%)                                
      Necrosis                                                                                1 (2%)                                
      Nephropathy                                     43 (88%)     45 (90%)     45 (90%)     48 (96%)                               
      Artery, Inflammation, Chronic Active                          1 (2%)                                                          
      Cortex, Cyst                                    10 (20%)     27 (54%)     20 (40%)     14 (28%)                               
      Papilla, Mineralization                                       1 (2%)                                                          

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05187-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           METHYLEUGENOL                                       Date: 07/20/98  
Route: GAVAGE                                                                                                     Time: 10:15:51  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      37 MG/KG     75 MG/KG     150                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Papilla, Necrosis                                             1 (2%)                                                          
      Pelvis, Transitional Epithelium, Hyperplasia                  1 (2%)                                                          
      Renal Tubule, Pigmentation, Hemosiderin                                                 1 (2%)                                
   Urinary Bladder                                    (49)         (50)         (50)         (50)                                   
      Calculus Gross Observation                                    1 (2%)                                                          
      Infiltration Cellular, Lymphocyte                6 (12%)      5 (10%)      9 (18%)     14 (28%)                               
      Inflammation, Chronic Active                     1 (2%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------